相似文献
1
Diagnosis and Management of Type 2 Diabetic Kidney Disease.
Clin J Am Soc Nephrol. 2017 Aug 7;12(8):1366-1373. doi: 10.2215/CJN.11111016. Epub 2017 Mar 9.
2
GLP-1 Receptor Agonists in Diabetic Kidney Disease.
Clin J Am Soc Nephrol. 2021 Oct;16(10):1578-1580. doi: 10.2215/CJN.18771220. Epub 2021 Apr 13.
3
Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".
Nutr Metab Cardiovasc Dis. 2019 Nov;29(11):1127-1150. doi: 10.1016/j.numecd.2019.07.017. Epub 2019 Oct 2.
4
Review of glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes mellitus in patients with chronic kidney disease and their renal effects.
J Diabetes. 2019 Dec;11(12):938-948. doi: 10.1111/1753-0407.12969. Epub 2019 Aug 14.
5
National survey: Evaluation of cardiovascular risk factors in Thai patients with type 2 diabetes and chronic kidney disease after the development of cardiovascular disease.
Nephrology (Carlton). 2018 Jan;23(1):53-59. doi: 10.1111/nep.12922.
6
High prevalence of chronic kidney disease in Finnish patients with type 2 diabetes treated in primary care.
Prim Care Diabetes. 2015 Feb;9(1):31-8. doi: 10.1016/j.pcd.2014.06.001. Epub 2014 Jul 21.
7
Relationship between albuminuric CKD and diabetic retinopathy in a real-world setting of type 2 diabetes: Findings from No blind study.
Nutr Metab Cardiovasc Dis. 2019 Sep;29(9):923-930. doi: 10.1016/j.numecd.2019.05.065. Epub 2019 Jun 7.
8
Relation between Blood Pressure Management and Renal Effects of Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Patients with Chronic Kidney Disease.
J Diabetes Res. 2019 Nov 3;2019:9415313. doi: 10.1155/2019/9415313. eCollection 2019.
9
[Difficult therapy in patients with renal failure. What protects, what damages the kidneys?].
MMW Fortschr Med. 2005 Apr 21;147(16):4-6.
10
Effects of glucose-lowering agents on surrogate endpoints and hard clinical renal outcomes in patients with type 2 diabetes.
Diabetes Metab. 2019 Apr;45(2):110-121. doi: 10.1016/j.diabet.2018.10.003. Epub 2018 Oct 25.
引用本文的文献
1
Kidney transcriptomics signature of prospective rapid diabetic kidney disease progression.
BMC Nephrol. 2025 Aug 31;26(1):504. doi: 10.1186/s12882-025-04364-0.
2
Decreased Serum Adipose Triglyceride Lipase Level Is Associated With Renal Function Impairment in Patients With Type 2 Diabetes.
J Diabetes Res. 2025 Jul 24;2025:9987648. doi: 10.1155/jdr/9987648. eCollection 2025.
3
Influence of metabolism-related comorbidities and insulin resistance on new onset of chronic kidney disease in a health check-up population: a two-stage retrospective cohort study.
BMJ Open Diabetes Res Care. 2025 Jul 27;13(4):e005137. doi: 10.1136/bmjdrc-2025-005137.
4
Heart rate turbulence in type 2 diabetes mellitus with chronic kidney disease.
PLoS One. 2025 Jul 15;20(7):e0319116. doi: 10.1371/journal.pone.0319116. eCollection 2025.
5
Identification of Shared Biomarkers in Chronic Kidney Disease and Diabetic Nephropathy Using Single-Cell Sequencing.
Diabetes Metab Syndr Obes. 2025 Jul 5;18:2155-2174. doi: 10.2147/DMSO.S514319. eCollection 2025.
6
Overexpression of GPX4 in diabetic rat kidney alleviates renal injury induced by ferroptosis.
Biometals. 2025 Jul 6. doi: 10.1007/s10534-025-00706-5.
7
Uncovering key markers and therapeutic targets for renal fibrosis in diabetic kidney disease through bulk and single-cell RNA sequencing.
J Transl Med. 2025 Jul 4;23(1):742. doi: 10.1186/s12967-025-06554-8.
8
Association between the serum Klotho levels and diabetic kidney disease: results from the NHANES 2007-2016 and Mendelian randomization study.
J Diabetes Metab Disord. 2025 Jun 25;24(2):156. doi: 10.1007/s40200-025-01623-7. eCollection 2025 Dec.
9
The serum uric acid to creatinine ratio as a diagnostic biomarker for normoalbuminuric diabetic kidney disease.
Front Med (Lausanne). 2025 May 14;12:1584049. doi: 10.3389/fmed.2025.1584049. eCollection 2025.
10
Huangkui capsules regulate tryptophan metabolism to improve diabetic nephropathy through the Keap1/Nrf2/HO-1 pathway.
Front Pharmacol. 2025 Apr 30;16:1535352. doi: 10.3389/fphar.2025.1535352. eCollection 2025.
Zotero 插件